Efficacy and safety of denosumab biosimilars in the treatment of postmenopausal osteoporosis: A systematic review of randomized clinical trials. [PDF]
Shakibaei F +3 more
europepmc +1 more source
Risk prediction models for postmenopausal osteoporosis: a systematic review and meta-analysis study. [PDF]
Li L, Lan X, Zeng W, Xu Y, Chen Q.
europepmc +1 more source
Exploration of pathogenesis and targeted drugs of postmenopausal osteoporosis by means of analysis based on reverse network pharmacology. [PDF]
Wu D, Zhao W, Ni Y.
europepmc +1 more source
The influence of immune regulation mediated by intestinal microbiota on postmenopausal osteoporosis and intervention strategies. [PDF]
Wang L +5 more
europepmc +1 more source
Nandrolone Decanoate for Postmenopausal Osteoporosis: A Systematic Review and Meta-Analysis of Randomized Trials. [PDF]
Camara LC, Ferreira MH, Junior NC.
europepmc +1 more source
Bone-targeted celastrol nanocarrier suppresses osteoclastogenesis in postmenopausal osteoporosis. [PDF]
Yu X, Zhang S, Wei Z, Xu Q.
europepmc +1 more source
Risk factors for secondary fractures in postmenopausal osteoporosis: A retrospective study. [PDF]
Zhang H, Du Y, Hu L.
europepmc +1 more source
Construction of a nomogram prediction model for individualized prediction of vertebral compression fracture risk in postmenopausal osteoporosis population. [PDF]
Chen J, Wei B, Cai J, Lin H, Huang C.
europepmc +1 more source
Performance of clinical prediction models for identifying postmenopausal osteoporosis: a systematic review and meta-analysis. [PDF]
Huang X +12 more
europepmc +1 more source

